Preliminary scientific tests show conolidine could inhibit unique ion channels, cutting down neuronal excitability and limiting soreness indicators. This mechanism is especially appropriate in neuropathic soreness, wherever irregular signaling results in persistent discomfort. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to suffering percept... https://amird503nuw4.wikicommunication.com/user